NDC 17433-9878-1 - DocuSol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17433-9878
- Requested NDC
- 17433-9878-1
- Package NDCs from labels
- 17433-9878-1, 17433-9878-5, 17433-9878-3
- Manufacturer
- Enemeez LLC DBA Summit Pharmaceuticals
- Effective date
- 2022-11-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DocuSol - Enemeez LLC DBA Summit Pharmaceuticals | Enemeez LLC DBA Summit Pharmaceuticals | 2022-11-08 | HUMAN OTC DRUG LABEL |
| Docusol - Enemeez Inc. DBA Summit Pharmaceuticals | Enemeez Inc. DBA Summit Pharmaceuticals | 2015-04-06 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17433-9878-3 | 2023-01-13 | C162847 | 48780-1 | 9d75b9d0-2d8e-f424-e053-dadaa90a57ce | 1235366d-b572-3a41-e054-00144ff8d46c |
| 17433-9878-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2d8e-f424-e053-dadaa90a57ce | 1235366d-b572-3a41-e054-00144ff8d46c |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17433-9878-1 | EA - Each | 17433-9878 | bec574c2-ca74-46b5-bf9a-34ee462aed70 | 1 | 2016-01-13 |
| 17433-9878-5 | EA - Each | 17433-9878 | 3e4b22f5-0f85-42c5-b015-d4c7beb48ad1 | 1 | 2013-09-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 2 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 2 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 1 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | DOCUSOL (DOCUSATE SODIUM) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lights Lemon Glycerin | GLYCERIN | Lights Medical Manufacture Co., Ltd. | c38638af-f367-4780-8295-022d959e79ca | 2026-11-09 | Warnings | PDC6A3C0OX |
| Colon Detox | DOCUSATE SODIUM AND SENNOSIDES | OPMX LLC | 0a4d3265-080c-d2ed-e063-6394a90adbee | 2026-11-04 | Warnings | F05Q2T2JA0 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2026-11-03 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Shield Line LLC | 5f635795-cb5b-cab4-e063-6394a90a7a9a | 2026-11-03 | Warnings | PDC6A3C0OX |
| Huddle Barrier Balm | GLYCERIN | Better Barrier Co. | 5b3cf1ed-082b-15cf-e063-6394a90a688e | 2026-11-02 | Warnings | PDC6A3C0OX |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | F05Q2T2JA0 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Docusate Mini Enema | DOCUSATE SODIUM | Major Pharmaceuticals | 91099e15-94d7-b684-e053-2a95a90a574e | 2026-10-23 | Warnings | F05Q2T2JA0 |
| CVS Mini Enema | DOCUSATE SODIUM W/BENZOCAINE | CVS HEALTH | ca00c520-410a-1905-e053-2995a90a56f0 | 2026-10-23 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | ATLANTIC BIOLOGICALS CORP. | c1f588d0-4600-4b97-b2d3-2c08ac351e07 | 2026-10-23 | Warnings | F05Q2T2JA0 |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Docusate Sodium | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6a7e4193-22d2-491e-9842-5c43f571fc65 | 2026-10-16 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.